U.S. Physical Therapy, Inc. Stock 12‑Month Price Target Raised to $99, Implies 11% Upside

What happened

Analysts’ average 12-month price target for U.S. Physical Therapy, Inc. rose from $97.83 to $99, implying about 11% potential upside from the Nov. 4 closing price. Forecasts range from $95 to $102 per share, while the consensus rating remains Buy among seven analysts.

Confirmed

Global impact / market context

A higher target signals that analysts see more potential value in the shares, but it does not directly change the company’s revenue, costs, or cash available. Investors may use the revision when deciding whether expected returns justify the stock’s risk.

Analyst inference

The target increase is modest, and the rating mix remains six Buys, one Hold, and no Sells among seven covering analysts. The stated 11% potential upside is measured against the Nov. 4 closing price, not a guaranteed return.

Confirmed

What to watch

1. Future analyst target changes could show whether the rise to $99 is sustained or reversed; the article gives no reasons for the revisions or forecasts. Analyst inference
2. The company’s future financial results could clarify whether analysts’ higher valuation expectations are supported by revenue and costs; no operating results are included here. Analyst inference
3. The consensus rating is still Buy, with six Buys and one Hold among seven analysts; any reported shift in that mix would change the stated consensus. Confirmed

Evidence

• Original source link unavailable